LIGAND-INDEPENDENT ACTIVATION OF THE PLATELET-DERIVED GROWTH-FACTOR-BETA RECEPTOR - REQUIREMENTS FOR BOVINE PAPILLOMAVIRUS E5-INDUCED MITOGENIC SIGNALING
D. Drummondbarbosa et al., LIGAND-INDEPENDENT ACTIVATION OF THE PLATELET-DERIVED GROWTH-FACTOR-BETA RECEPTOR - REQUIREMENTS FOR BOVINE PAPILLOMAVIRUS E5-INDUCED MITOGENIC SIGNALING, Molecular and cellular biology, 15(5), 1995, pp. 2570-2581
The E5 protein of bovine papillomavirus type 1 binds to and activates
the endogenous platelet-derived growth factor (PDGF) beta receptor in
fibroblasts, resulting in cell transformation. We have developed a fun
ctional assay to test the ability of PDGF beta receptor mutants to med
iate a mitogenic signal initiated by the E5 protein. Lymphoid Ba/F3 ce
lls are strictly dependent on interleukin-3 for growth, but coexpressi
on of the wild-type PDGF beta receptor and the E5 or v-sis-encoded pro
tein generated a mitogenic signal which allowed Ba/F3-derived cells to
proliferate in the absence of interleukin-3. In these cells, the E5 p
rotein bound to and caused increased tyrosine phosphorylation of both
the mature and the precursor forms of the wild-type PDGF beta receptor
. The tyrosine kinase activity of the receptor was necessary for E5-in
duced receptor tyrosine phosphorylation and mitogenic activity but not
for complex formation with the E5 protein. In contrast, the PDGF-bind
ing domain of the receptor was not required for complex formation with
the E5 protein, E5-induced tyrosine phosphorylation or mitogenic acti
vity, demonstrating that E5-mediated receptor activation is ligand ind
ependent. Analysis of receptor mutants lacking various combinations of
tyrosine phosphorylation sites revealed that the E5 and v-sis-encoded
proteins display similar requirements for signaling and suggested tha
t the wild-type PDGF beta receptor can generate multiple independent m
itogenic signals. Importantly, these mutants dissociated two activitie
s of the PDGF beta receptor tyrosine kinase, both of which are require
d for sustained mitogenic signaling: (i) receptor autophosphorylation
and creation of binding sites for SH2 domain-containing proteins and (
ii) phosphorylation of substrates other than the receptor itself.